trending Market Intelligence /marketintelligence/en/news-insights/trending/OQmqEhwG-yUyVqh1Ulqttw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Cerulean exploring strategic alternatives

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Cerulean exploring strategic alternatives

Cerulean Pharma Inc.'s board is conducting a comprehensive review of strategic options to maximize shareholder value.

The review is to evaluate potential alternatives such as the sale of the company; a merger; a business combination; a strategic investment in the company; or a sale, license or disposition of its assets.

Also in the review, the board is considering certain clinical assets, the company's nanoparticle-drug conjugates platform and cash reserves.